Licensed clinic & professional formulary
PureVital logo
Formulary / Clinic Support / Tofacitinib 2%
Tofacitinib 2% — PureVital
PureVital
CreamIn stock

Strength

2% (50g)

Total API

1 gm

Form

Cream

Brand

PureVital

Clinic Support

Tofacitinib 2%

Topical JAK inhibitor cream for dermatology-oriented clinics

PV-TOFACITINIB-2--250G

Professional price

$103.99

View monograph

Tofacitinib 2% cream provides a topical Janus kinase (JAK) inhibitor option for clinics managing inflammatory dermatologic presentations under professional protocols. Presentation: 2% (50g) (Cream); total API 1 gm. For licensed clinics and practitioners.

  • Topical JAK inhibitor cream for dermatology-oriented clinics
  • Strength: 2% (50g)
  • Total API: 1 gm
  • Cream presentation for licensed clinic programs
Licensed clinic formulary
Label-first SKU detail
Wholesale & bulk desk

PureVital Clinical Formulary — Strength & Volume updates April 2026

Mechanism themes

Receptor and pathway context written for clinic teams.

Clinic-use references

Titration and presentation notes — not patient prescriptions.

Safety & regulatory

Precautions, interactions, and status framing in one monograph.

Clinical monograph

Professional product details

Topical JAK inhibitor cream for dermatology-oriented clinics. Structured for licensed clinics — mechanism, clinic-use themes, safety, and package clarity in one place.

Compound family

tofacitinib

Overview

Tofacitinib 2% cream provides a topical Janus kinase (JAK) inhibitor option for clinics managing inflammatory dermatologic presentations under professional protocols.

Label-first clinic supply presentation

Contents of the package

What arrives for this PureVital SKU

  • 1 × 2% (50g) cream presentation
  • Active listing: Tofacitinib 2%
  • Total API (label): 1 gm
  • SKU PV-TOFACITINIB-2--250G
  • Topical cream jar — apply only as directed by the clinic
  • PureVital professional clinical formulary supply

About topical tofacitinib

Systemic tofacitinib is a known JAK inhibitor; topical compounding aims for local immunomodulation with lower systemic exposure — still requiring informed consent and monitoring judgment.

Clinic notes

01

Start low

02

Assess GI

03

Escalate

04

Maintain

  • 2% cream in a 50 g jar (1 g total API labeled)
  • Apply thin films to directed areas per dermatology protocol
  • Counsel on hand washing and avoiding mucous membranes unless directed

Safety

  • Local irritation or infection risk at application sites
  • Discuss JAK-class infection and malignancy counseling themes as appropriate
  • Avoid in pregnancy unless specialist-directed
  • Do not use on open wounds unless protocol allows

Educational formulary information for licensed clinics and practitioners only. PureVital presents professional supplement / wellness formulary items — not regular medicines. Final presentation choice, titration, and monitoring remain clinical decisions. Not intended to diagnose, treat, cure, or prevent any disease.

Continue browsing

Related formulary items

Same category presentations clinics often review together.

View Clinic Support